Treatment of murine lupus with monoclonal antibodies to lymphocyte function-associated antigen-1: dose-dependent inhibition of autoantibody production and blockade of the immune response to therapy.

Connolly, M K

Treatment of murine lupus with monoclonal antibodies to lymphocyte function-associated antigen-1: dose-dependent inhibition of autoantibody production and blockade of the immune response to therapy. [electronic resource] - Clinical immunology and immunopathology Aug 1994 - 198-203 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

0090-1229

10.1006/clin.1994.1130 doi


Animals
Antibodies, Monoclonal--therapeutic use
Autoantibodies--biosynthesis
Autoimmune Diseases--etiology
Autoimmunity--physiology
DNA--immunology
Disease Models, Animal
Dose-Response Relationship, Drug
Immunotherapy
Lupus Vulgaris--immunology
Lymphocyte Function-Associated Antigen-1--immunology
Lymphocyte Subsets--drug effects
Lymphocytosis--chemically induced
Mice
Mice, Inbred Strains
Rats